|Awarded On||August 21, 2019|
|Title||High Performance Mass Spectrometry Imaging Core Facility|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||The University of Texas at Austin|
|Principal Investigator/Program Director||Jennifer S Brodbelt|
|Cancer Sites||All Sites|
*Pending contract negotiation
Mass spectrometry (MS) imaging has emerged as a revolutionary method for molecular mapping of tissue. The depth of spatial and molecular information from MS imaging has immense diagnostic, prognostic and mechanistic value for basic, translational, and clinical cancer research. We propose to establish a state-of-the art MS imaging center that will serve and support cancer researchers throughout Texas, working on ovarian, brain, breast, pancreatic, cervical and thyroid cancer, among others. Conventional tissue biopsy is based on the evaluation of morphological features of the tissue by a trained pathologist, a subjective process. In contrast, hundreds of clearly defined molecular features diag...